Evidence map›Paper›PMID 40689876›Full record

Trial reporteLife2025

Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance.

Hans Kirschner, Hanna M Molla, Matthew R Nassar, Harriet de Wit, Markus Ullsperger

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07664631 (Effects of Stimulant Medications in PTSD), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07664631 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effects of Stimulant Medications in PTSD

TypeinterventionalSponsorUniversity of ChicagoRan2026 to 2027Enrolled40ConditionsAdderall, PTSD, Post Traumatic Stress DisorderArmsPlacebo, Adderall
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Hans KirschnerInstitute of Psychology, Otto-von-Guericke University, Magdeburg, Germany.ORCID https://orcid.org/0000-0001-9747-1746
Hanna M MollaDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, United States.ORCID https://orcid.org/0000-0002-2971-4512
Matthew R NassarRobert J. and Nancy D. Carney Institute for Brain Science, Brown University, Providence, United States.ORCID https://orcid.org/0000-0002-5397-535X
Harriet de Wit *Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, United States.ORCID https://orcid.org/0000-0002-7211-8994
Markus Ullsperger *Institute of Psychology, Otto-von-Guericke University, Magdeburg, Germany.ORCID https://orcid.org/0000-0003-3970-1982

Funding

Determinants of Drug Preference in Humans--Administrative SupplementR01DA002812 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1985 to 2024
$10.6M
CLINICAL THERAPEUTICST32GM007019 · NIGMS · UNIVERSITY OF CHICAGO · PI Peter Hugh O'Donnell, MARK J RATAIN · 1985 to 2026
$8.7M
Deutsche Forschungsgemeinschaft SFB 1436European Research Council 10.3030/101018805NIDA NIH HHS DA02812NIDA NIH HHS R01 DA002812NIGMS NIH HHS T32 GM007019NIH HHS T32 GM07019
6 · The paper itself

Abstract

The ability to calibrate learning according to new information is a fundamental component of an organism's ability to adapt to changing conditions. Yet, the exact neural mechanisms guiding dynamic learning rate adjustments remain unclear. Catecholamines appear to play a critical role in adjusting the degree to which we use new information over time, but individuals vary widely in the manner in which they adjust to changes. Here, we studied the effects of a low dose of methamphetamine (MA), and individual differences in these effects, on probabilistic reversal learning dynamics in a within-subject, double-blind, randomized design. Participants first completed a reversal learning task during a drug-free baseline session to provide a measure of baseline performance. Then they completed the task during two sessions, one with MA (20 mg oral) and one with placebo (PL). First, we showed that, relative to PL, MA modulates the ability to dynamically adjust learning from prediction errors. Second, this effect was more pronounced in participants who performed moderately low at baseline. These results present novel evidence for the involvement of catecholaminergic transmission on learning flexibility and highlights that baseline performance modulates the effect of the drug.

Indexed as

Central Nervous System StimulantsLearningMethamphetamineReversal LearningAdultDouble-Blind MethodFemaleHumansMaleYoung AdultCentral Nervous System StimulantsMethamphetaminecatecholaminescomputational neurosciencehumanlearningneuroscience

Identifiers

PMID40689876
PMCPMC12279372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.